BNP PARIBAS FINANCIAL MARKETS - EVELO BIOSCIENCES INC ownership

EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 50 filers reported holding EVELO BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of EVELO BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$301
-88.0%
1,668
+7.4%
0.00%
Q4 2022$2,500
-99.8%
1,553
+139.7%
0.00%
Q3 2022$1,354,000
-82.5%
648
-82.4%
0.00%
Q2 2022$7,750,000
-21.8%
3,673
+25.6%
0.00%
Q1 2022$9,916,000
-75.9%
2,925
-56.9%
0.00%
Q4 2021$41,203,000
+2.8%
6,788
+19.3%
0.00%
Q3 2021$40,072,000
+281.2%
5,692
+644.1%
0.00%
Q2 2021$10,511,000
-62.6%
765
-70.9%
0.00%
Q1 2021$28,141,000
-41.5%
2,630
-33.9%
0.00%
Q4 2020$48,070,000
+96.2%
3,976
-14.5%
0.00%
Q3 2020$24,506,000
+213.0%
4,650
+191.0%
0.00%
Q2 2020$7,830,000
-50.5%
1,598
-62.0%
0.00%
Q1 2020$15,809,000
+30.6%
4,210
+41.2%
0.00%
Q4 2019$12,103,000
-13.4%
2,981
+30.1%
0.00%
Q3 2019$13,981,000
-28.4%
2,292
+5.5%
0.00%
Q2 2019$19,514,000
-17.6%
2,173
-26.6%
0.00%
Q1 2019$23,680,000
+1815.9%
2,960
+3015.8%
0.00%
Q4 2018$1,236,000
-42.0%
95
-45.7%
0.00%
Q3 2018$2,132,000
+3.2%
1750.0%0.00%
Q2 2018$2,065,0001750.00%
Other shareholders
EVELO BIOSCIENCES INC shareholders Q4 2020
NameSharesValueWeighting ↓
HARBOURVEST PARTNERS LLC 3,063,505$37,038,00014.47%
Mayo Clinic 484,953$5,863,0007.05%
Flagship Pioneering Inc. 22,900,069$276,862,0005.04%
Trustees of Columbia University in the City of New York 113,850$1,376,0001.84%
Alphabet Inc. 1,060,495$12,821,0000.62%
Artal Group S.A. 700,000$8,463,0000.18%
Larson Financial Group LLC 28,353$343,0000.12%
PEDDOCK CAPITAL ADVISORS, LLC 3,663$44,0000.02%
CREDIT SUISSE AG/ 2,705,511$32,710,0000.02%
FMR LLC 6,803,365$82,253,0000.01%
View complete list of EVELO BIOSCIENCES INC shareholders